These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21962991)

  • 1. Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection.
    Navarini AA; French LE; Hofbauer GF
    J Allergy Clin Immunol; 2011 Nov; 128(5):1128-30. PubMed ID: 21962991
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis: A Meta-analysis of Randomized Clinical Trials.
    Xiao X; Lin L; Zhu C; Yang X; Ni Y; Zhipeng L; Chong J; Han Y
    J Investig Allergol Clin Immunol; 2021 Apr; 31(2):190-192. PubMed ID: 33876738
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of conjunctivitis with a conjunctival proliferative lesion in a patient treated with dupilumab for atopic dermatitis.
    Fukuda K; Ishida W; Kishimoto T; Fukushima A
    Allergol Int; 2019 Jul; 68(3):383-384. PubMed ID: 30718036
    [No Abstract]   [Full Text] [Related]  

  • 4. Omalizumab treatment in severe adult atopic dermatitis.
    Thaiwat S; Sangasapaviliya A
    Asian Pac J Allergy Immunol; 2011 Dec; 29(4):357-60. PubMed ID: 22299316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy with anti-interleukin-31 receptor A antibody for atopic dermatitis.
    Fioranelli M; Roccia MG; Lotti T
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28394466
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute onset of psoriasis in a patient with atopic dermatitis treated with dupilumab.
    Ferrucci S; Tavecchio S; Berti E; Angileri L
    Clin Exp Dermatol; 2020 Jul; 45(5):625-626. PubMed ID: 32112580
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-immunoglobulin e in the treatment of refractory atopic dermatitis.
    Amrol D
    South Med J; 2010 Jun; 103(6):554-8. PubMed ID: 20710140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study.
    Sheinkopf LE; Rafi AW; Do LT; Katz RM; Klaustermeyer WB
    Allergy Asthma Proc; 2008; 29(5):530-7. PubMed ID: 18926061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Success of omalizumab as monotherapy in adult atopic dermatitis: case report and discussion of the high-affinity immunoglobulin E receptor, FcepsilonRI.
    Forman SB; Garrett AB
    Cutis; 2007 Jul; 80(1):38-40. PubMed ID: 17725062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels.
    Belloni B; Ziai M; Lim A; Lemercier B; Sbornik M; Weidinger S; Andres C; Schnopp C; Ring J; Hein R; Ollert M; Mempel M
    J Allergy Clin Immunol; 2007 Nov; 120(5):1223-5. PubMed ID: 17936892
    [No Abstract]   [Full Text] [Related]  

  • 11. Omalizumab efficacy in a girl with atopic eczema.
    Caruso C; Gaeta F; Valluzzi RL; Romano A
    Allergy; 2010 Feb; 65(2):278-9. PubMed ID: 19796201
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term treatment of severe recalcitrant atopic dermatitis with omalizumab, an anti-immuno-globulin E.
    Quist SR; Ambach A; Göppner D; Quist J; Franke I; Bonnekoh B; Gollnick HP
    Acta Derm Venereol; 2013 Mar; 93(2):206-8. PubMed ID: 23042516
    [No Abstract]   [Full Text] [Related]  

  • 13. Early onset of alopecia areata after dupilumab introduction in a patient with atopic dermatitis.
    Barbarin C; Hosteing S; Nosbaum A; Allouchery M; Celerier P
    Eur J Dermatol; 2019 Oct; 29(5):542-543. PubMed ID: 31789276
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis.
    Incorvaia C; Pravettoni C; Mauro M; Yacoub MR; Tarantini F; Riario-Sforza GG
    Monaldi Arch Chest Dis; 2008 Jun; 69(2):78-80. PubMed ID: 18837422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nemolizumab-induced drug eruption in a 46-year-old male patient with atopic dermatitis.
    Kamada H; Arakawa N; Fukui R; Tanji T; Watabe D; Sugai T; Amano H
    Eur J Dermatol; 2023 Oct; 33(5):558-559. PubMed ID: 38297936
    [No Abstract]   [Full Text] [Related]  

  • 16. Psoriasis-like lesions in an atopic dermatitis patient possibly associated with nemolizumab treatment.
    Masuda T; Yonekura S; Kataoka K; Mizoguchi K; Hirata M; Fujimoto M; Nakajima S; Kabashima K
    J Dermatol; 2024 Jun; 51(6):e193-e195. PubMed ID: 38149402
    [No Abstract]   [Full Text] [Related]  

  • 17. Olopatadine hydrochloride decreases tissue interleukin-31 levels in an atopic dermatitis mouse model.
    Murota H; El-latif MA; Tamura T; Katayama I
    Acta Derm Venereol; 2014 Jan; 94(1):78-9. PubMed ID: 23817562
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cataract progression in patients with atopic dermatitis].
    Mrugacz M; Bakunowicz-Łazarczyk A; Antosiuk R; Minarowska A
    Klin Oczna; 2002; 104(5-6):403-5. PubMed ID: 12664491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dupixent® (Dupilumab): A Newly Approved Interleukin-4 Receptor Antagonist for the Treatment of Atopic Dermatitis in Pediatric Patients.
    Gupta AK; Love RP; Abramovits W; Vincent KD
    Skinmed; 2019; 17(2):107-109. PubMed ID: 31145061
    [No Abstract]   [Full Text] [Related]  

  • 20. [Keratoconjunctivitis associated with atopic dermatitis treated with tocilizumab].
    Raga Jiménez C; Álvarez Martín T; Ferrando Piqueres R; Pitarch Bort G
    Farm Hosp; 2018 Jan; 42(1):29-30. PubMed ID: 29306313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.